Produced by Araxis Merge on 2/19/2018 2:07:48 PM Eastern Standard Time. See www.araxis.com for information about Merge. This report uses XHTML and CSS2, and is best viewed with a modern standards-compliant browser. For optimum results when printing this report, use landscape orientation and enable printing of background images and colours in your browser.
| # | Location | File | Last Modified |
|---|---|---|---|
| 1 | OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package.zip\OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package\OneVA_Pharmacy_CAS_MPDU_Build-2_Test_Cases | CAS_MPDU_TC_027_ Prevent edits of restricted fields on Controlled Substance Prescriptions.docx | Mon Jan 8 17:03:06 2018 UTC |
| 2 | OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package.zip\OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package\OneVA_Pharmacy_CAS_MPDU_Build-2_Test_Cases | CAS_MPDU_TC_027_ Prevent edits of restricted fields on Controlled Substance Prescriptions.docx | Mon Feb 19 17:29:57 2018 UTC |
| Description | Between Files 1 and 2 |
|
|---|---|---|
| Text Blocks | Lines | |
| Unchanged | 1 | 1100 |
| Changed | 0 | 0 |
| Inserted | 0 | 0 |
| Removed | 0 | 0 |
| Whitespace | |
|---|---|
| Character case | Differences in character case are significant |
| Line endings | Differences in line endings (CR and LF characters) are ignored |
| CR/LF characters | Not shown in the comparison detail |
No regular expressions were active.
| 1 | Department of Vetera ns Affairs | |
| 2 | ||
| 3 | Clinical A ncillary S ervices (C AS) | |
| 4 | ||
| 5 | ||
| 6 | Build 2 | |
| 7 | Sprint-2 | |
| 8 | Test Case CAS_TC_027 | |
| 9 | ||
| 10 | CLIN# 0004 AE | |
| 11 | November 2 017 | |
| 12 | Version 1. 0 | |
| 13 | Revision H istory | |
| 14 | Date | |
| 15 | Version | |
| 16 | Descriptio n | |
| 17 | Author | |
| 18 | 08/04/2017 | |
| 19 | 1.0 | |
| 20 | Initial dr aft | |
| 21 | Joseph A. McGovern | |
| 22 | Template R evision Hi story | |
| 23 | Date | |
| 24 | Version | |
| 25 | Descriptio n | |
| 26 | Author | |
| 27 | 08/04/2017 | |
| 28 | 1.0 | |
| 29 | Constructe d for CAS based on h istorical Test Case format use d on prior VA Projec ts | |
| 30 | Joseph A. McGovern | |
| 31 | ||
| 32 | ||
| 33 | Table of C ontents | |
| 34 | 1Product D escription 1 | |
| 35 | 1.1Purpose 1 | |
| 36 | 1.2Scope1 | |
| 37 | 2Test Case | |
| 38 | Appendix A .Acronyms & Abbrevia tions9 | |
| 39 | ||
| 40 | ||
| 41 | Product De scription | |
| 42 | OneVA Phar macy Clin ical Ancil lary Servi ces (CAS) project | |
| 43 | Purpose | |
| 44 | The purpos e of this document i s to devel op test ca se scenari os to iden tify, clar ify, and o rganize CA S applicat ion requir ements. Th e test cas e is made up of a se t of possi ble sequen ces of int eractions between sy stems and users in t he CHYSHR and DAYTSH R environm ents to va lidate and verify th at OneVA P harmacy so ftware Out patient Ph armacy Pre scription Processing will prev ented from updating restricted fields wh en select one or mor e fields t o update s o that do not inadve rtently up date a fie ld that is not suppo sed to be edited on a controll ed substan ce prescri ption caus ing me to be in viol ation of D EA regulat ions.. | |
| 45 | The CHYSHR environme nt is the Host site. The DAYT SHR enviro nment is t he dispens ing site ( remote). | |
| 46 | The test c ase should contain a ll system activities that have significa nce to the Pharmacis t users. | |
| 47 | Scope | |
| 48 | OneVA Phar macy softw are Outpat ient Pharm acy Prescr iption Pro cessing wi ll prevent ed from up dating res tricted fi elds when select one or more f ields to u pdate so t hat do no t inadvert ently upda te a field that is n ot suppose d to be ed ited on a controlled substance prescript ion causin g me to be in violat ion of DEA regulatio ns.. | |
| 49 | Test Case | |
| 50 | CAS Test C ases and s upporting test scrip ts will be recorded managed in VA Enterp rise Jazz Rational Q uality Man ager Tool PBM(QM). Stakeholde rs can als o provide inputs abo ut the cur rent set o f test cas es as well as sugges t some mor e missing test cases . | |
| 51 | This test case will: | |
| 52 | Capture an d communic ate functi onal requi rements fo r software developme nt; and | |
| 53 | Provide a set of tes t inputs, execution conditions , and expe cted resul ts develop ed for a p articular objective, such as t o exercise a particu lar progra m path or to verify compliance with a sp ecific req uirement o r defect r emediation . | |
| 54 | Prevented from updat ing restri cted field s when sel ect one or more fiel ds to upda te so that do not in advertentl y update a field tha t is not s upposed to be edited on a cont rolled sub stance pre scription. | |
| 55 | When the e dits restr icted, pre sent the u ser with t he followi ng error m essage | |
| 56 | “The selec tion inclu des fields that are not editab le for con trolled su bstances. These fie lds will b e skipped. ” | |
| 57 | ||
| 58 | Field | |
| 59 | Descriptio n | |
| 60 | Test Case ID: | |
| 61 | CAS_ Build 2_Sprint 1_CAS_MPDU _TC_027_ P revent edi ts of rest ricted fie lds on Con trolled Su bstance Pr escription s | |
| 62 | RTC ID: | |
| 63 | 607637 | |
| 64 | RM ID: | |
| 65 | 944733 | |
| 66 | QM ID: | |
| 67 | 165364 | |
| 68 | Tester: | |
| 69 | Samatha Gi rla | |
| 70 | Environmen t: | |
| 71 | DAYTSHR | |
| 72 | Build : | |
| 73 | PSD_3_83_2 0171109.KI D,PSO_7_50 5_20171109 .KID | |
| 74 | Use Case N ame: | |
| 75 | Electronic capture o f all info rmation re quired to fill presc riptions f or control led substa nces | |
| 76 | Scenario: | |
| 77 | As a pharm acist edit ing a pres cription o rder on a controlled substance , I want t o be preve nted from updating r estricted fields whe n I select one or mo re fields to update so that I do not ina dvertently update a field that is not su pposed to be edited on a contr olled subs tance pres cription c ausing me to be in v iolation o f DEA regu lations. | |
| 78 | Actors: | |
| 79 | Pharmacist | |
| 80 | Pre-Condit ion: | |
| 81 | The Pharma cist must have an ac tive VistA account w ith access to the On eVA Pharma cy Program . | |
| 82 | ||
| 83 | Scenario 1 : Patient should hav e at least one activ e controll ed substan ce prescr iptions | |
| 84 | ||
| 85 | Scenario 2 : Patient should hav e at least one pendi ng control led substa nce presc riptions | |
| 86 | ||
| 87 | Post-Condi tion | |
| 88 | Upon entry of valid access and verify co des on Out Patient Ph armacy Pre scription Processing system sh ould Preve nt edits o f restrict ed fields on Control led Substa nce Prescr iptions | |
| 89 | ||
| 90 | Steps | |
| 91 | ||
| 92 | Pass | |
| 93 | Fail | |
| 94 | ||
| 95 | Scenario 1 :Block edi ts on rest ricted fie lds for Ac tive contr olled subs tance pre scriptions | |
| 96 | ||
| 97 | ||
| 98 | ||
| 99 | Actions | |
| 100 | Pass | |
| 101 | ||
| 102 | ||
| 103 | Log into t he ‘HOST’ system DA YTSHR . | |
| 104 | ||
| 105 | ||
| 106 | ||
| 107 | Expected R esults | |
| 108 | ||
| 109 | ||
| 110 | ||
| 111 | The ‘HOST’ system wi ll be the system tha t ‘owns’ t he prescri ption, or where the prescripti on was ori ginal writ ten. | |
| 112 | ||
| 113 | ||
| 114 | ||
| 115 | Actions | |
| 116 | Pass | |
| 117 | ||
| 118 | ||
| 119 | Enter your access/ve rify code( s). | |
| 120 | ||
| 121 | ||
| 122 | ||
| 123 | Expected R esults | |
| 124 | ||
| 125 | ||
| 126 | ||
| 127 | User it ta ken to the default m enu promp t. | |
| 128 | ||
| 129 | ||
| 130 | ||
| 131 | Actions | |
| 132 | Pass | |
| 133 | ||
| 134 | ||
| 135 | Choose Opt ion ‘PSO U SER1’ | |
| 136 | ||
| 137 | ||
| 138 | ||
| 139 | Expected R esults | |
| 140 | ||
| 141 | ||
| 142 | ||
| 143 | User is ta ken to the default m enu prompt . | |
| 144 | ||
| 145 | ||
| 146 | ||
| 147 | Actions | |
| 148 | Pass | |
| 149 | ||
| 150 | ||
| 151 | When promp ted “Selec t Systems Manager Me nu <TEST A CCOUNT> Op tion:” ent er PROGra mmer Optio ns, press <return> | |
| 152 | ||
| 153 | ||
| 154 | ||
| 155 | Expected R esults | |
| 156 | ||
| 157 | ||
| 158 | ||
| 159 | User is ta ken to the next prom pt. | |
| 160 | ||
| 161 | ||
| 162 | ||
| 163 | Actions | |
| 164 | Pass | |
| 165 | ||
| 166 | ||
| 167 | Select Pro grammer Op tions <TES T ACCOUNT> Option: P G Program mer mode | |
| 168 | ||
| 169 | ||
| 170 | ||
| 171 | Expected R esults | |
| 172 | ||
| 173 | ||
| 174 | ||
| 175 | User is ta ken to the next prom pt. | |
| 176 | ||
| 177 | ||
| 178 | ||
| 179 | Actions | |
| 180 | Pass | |
| 181 | ||
| 182 | ||
| 183 | When promp ted ‘ISPA0 4:DAYTSHR> ’ D ^XUP | |
| 184 | :”, press <return> | |
| 185 | ||
| 186 | ||
| 187 | ||
| 188 | Expected R esults | |
| 189 | ||
| 190 | ||
| 191 | ||
| 192 | User is ta ken to the next prom pt. | |
| 193 | ||
| 194 | ||
| 195 | ||
| 196 | Actions | |
| 197 | Pass | |
| 198 | ||
| 199 | ||
| 200 | Select OPT ION NAME: PSO USER1 | |
| 201 | ||
| 202 | ||
| 203 | ||
| 204 | Expected R esults | |
| 205 | ||
| 206 | ||
| 207 | ||
| 208 | System wil l ask to e nter divis ion | |
| 209 | ||
| 210 | ||
| 211 | ||
| 212 | Actions | |
| 213 | Pass | |
| 214 | ||
| 215 | ||
| 216 | Division:9 84 | |
| 217 | ||
| 218 | ||
| 219 | ||
| 220 | Expected R esults | |
| 221 | ||
| 222 | ||
| 223 | ||
| 224 | Select LAB EL PRINTER : HOME// SECURE Right Mar gin: 80// | |
| 225 | ||
| 226 | ||
| 227 | ||
| 228 | Actions | |
| 229 | Pass | |
| 230 | ||
| 231 | ||
| 232 | Press <Ret urn> until see the o ption Sele ct Pharmac ist Menu < TEST ACCOU NT> Option : then en ter RX and press <re tun> | |
| 233 | ||
| 234 | ||
| 235 | ||
| 236 | Expected R esults | |
| 237 | ||
| 238 | ||
| 239 | ||
| 240 | Do you wan t an Order Summary? No// | |
| 241 | ||
| 242 | ||
| 243 | 10 | |
| 244 | ||
| 245 | Actions | |
| 246 | ||
| 247 | ||
| 248 | ||
| 249 | Do you wan t an Order Summary? No// Press <Return> | |
| 250 | ||
| 251 | ||
| 252 | ||
| 253 | Expected R esults | |
| 254 | ||
| 255 | ||
| 256 | ||
| 257 | Select Rx (Prescript ions) <TES T ACCOUNT> Option: S hould be d isplayed o n the scre en | |
| 258 | ||
| 259 | ||
| 260 | 11 | |
| 261 | Actions | |
| 262 | ||
| 263 | ||
| 264 | ||
| 265 | Select Pat ient Presc ription Pr ocessing a nd press<R eturn> | |
| 266 | ||
| 267 | ||
| 268 | ||
| 269 | Expected R esults | |
| 270 | ||
| 271 | ||
| 272 | ||
| 273 | System wil l ask for Select PAT IENT NAME: | |
| 274 | ||
| 275 | ||
| 276 | 12 | |
| 277 | Actions | |
| 278 | ||
| 279 | ||
| 280 | ||
| 281 | Enter pati ent name w hich meets the pre c onditions mentioned | |
| 282 | For the te st case he re TEST,DA YTSHR used for the t esting | |
| 283 | ||
| 284 | ||
| 285 | ||
| 286 | Expected R esults | |
| 287 | ||
| 288 | ||
| 289 | ||
| 290 | System sho uld be dis played Wou ld you lik e to query prescript ions from other OneV A Pharmacy | |
| 291 | locations? YES | |
| 292 | ||
| 293 | ||
| 294 | 13 | |
| 295 | Actions | |
| 296 | ||
| 297 | ||
| 298 | ||
| 299 | Enter YES and press< return> | |
| 300 | ||
| 301 | ||
| 302 | ||
| 303 | Expected R esults | |
| 304 | ||
| 305 | ||
| 306 | ||
| 307 | REMOTE PRE SCRIPTIONS AVAILABLE ! | |
| 308 | Display Re mote Data? N// | |
| 309 | ||
| 310 | ||
| 311 | 14 | |
| 312 | Actions | |
| 313 | ||
| 314 | ||
| 315 | ||
| 316 | Press <Ret urn>until you see th e patient medication profile | |
| 317 | ||
| 318 | ||
| 319 | ||
| 320 | Expected R esults | |
| 321 | ||
| 322 | ||
| 323 | ||
| 324 | Patient me dication p rofile wil l be displ ayed with all prescr iptions | |
| 325 | Medication Profile Nov 20, 20 17@20:14:4 5 Page: 1 of 2 | |
| 326 | TEST,DAYTS HR | |
| 327 | PID: 090 -90-9090 Ht(cm): _ ______ (__ ____) | |
| 328 | DOB: JAN 1,1975 (4 2) Wt(kg): _ ______ (__ ____) | |
| 329 | SEX: FEM ALE | |
| 330 | CrCL: <No t Found> B SA (m2): _ ______ | |
| 331 | ISSUE LA ST REF DAY | |
| 332 | # RX # DRU G QTY ST DATE FI LL REM SUP | |
| 333 | + | |
| 334 | 1 2719137 AMI NOCAPROIC ACID 500MG TAB 30 A 11-08 11- 08 11 30 | |
| 335 | 2 2719135 AMO XAPINE 100 MG TAB 30 A> 11-08 11- 08 11 30 | |
| 336 | 3 2719138 DIG OXIN (LANO XIN) 0.125 MG TAB 30 A 11-08 11- 08 11 30 | |
| 337 | 4 2719140 LOR AZEPAM 1MG TAB 30 S> 11-13 12- 03 4 30 | |
| 338 | 5 2719136 t WAR FARIN (COU MADIN) NA 10MG WHITE TAB A 11-08 11- 08 0 30 | |
| 339 | Qty: 28 | |
| 340 | ---------- ---------- ---------- ------PEND ING------- ---------- ---------- ---------- | |
| 341 | 6 ACYCLOV IR 800MG T AB QTY: 60 I SDT: 07-26 > REF: 0 | |
| 342 | ---------- ---------- ------CHYS HR TEST LA B (983) AC TIVE------ ---------- ---------- | |
| 343 | 7 1000042 7 DIA ZEPAM 10MG TAB 125 A 11-08 11- 08 5 30 | |
| 344 | + Enter ?? f or more ac tions | |
| 345 | PU Patien t Record U pdate NO New Or der | |
| 346 | PI Patien t Informat ion SO Select Order | |
| 347 | Select Act ion: Next Screen// | |
| 348 | ||
| 349 | ||
| 350 | 15 | |
| 351 | Actions | |
| 352 | ||
| 353 | ||
| 354 | ||
| 355 | Select ac tive contr olled subs tance pres cription, here for t esting LOR AZEPAM 1MG TAB selec ted Actio n: Quit// 4 | |
| 356 | ||
| 357 | ||
| 358 | ||
| 359 | Expected R esults | |
| 360 | ||
| 361 | ||
| 362 | ||
| 363 | OP Medicat ions (SUSP ENDED) Nov 21, 20 17@09:57:4 8 Page: 1 of 3 | |
| 364 | TEST,DAYTS HR | |
| 365 | PID: 090 -90-9090 Ht(cm): _ ______ (__ ____) | |
| 366 | DOB: JAN 1,1975 (4 2) Wt(kg): _ ______ (__ ____) | |
| 367 | SEX: FEM ALE | |
| 368 | CrCL: <No t Found> B SA (m2): _ ______ | |
| 369 | ||
| 370 | Rx # : 2719140 | |
| 371 | (1) *Orde rable Item : LORAZEPA M TAB | |
| 372 | (2) CMOP Drug : LORAZEPA M 1MG TAB | |
| 373 | NDC : 00008-00 64-02 | |
| 374 | (3) *Dosage : 1 (MG) | |
| 375 | Verb : TAKE | |
| 376 | Disp ense Units : 1 | |
| 377 | Noun : TABLET | |
| 378 | *Route : BY MOUTH | |
| 379 | *Schedule : QAM | |
| 380 | (4)Pat In structions : | |
| 381 | SIG : TAKE ONE TABLET BY MOUTH EVE RY MORNING | |
| 382 | (5) Patie nt Status: SC | |
| 383 | (6) Issue Date : 11/13/17 (7) Fill Date: 11/13/17 | |
| 384 | Last Fill Date : 12/03/17 (Mail) | |
| 385 | Last Re lease Date : (8) Lot #: | |
| 386 | Expires : 05/16/18 MFG: | |
| 387 | (9) D ays Supply : 30 (10) QTY (TAB): 30 | |
| 388 | (11) # of Refills : 5 Remaining: 4 | |
| 389 | (12) Provider : HERRING, VENESSA | |
| 390 | DEA# : AH472991 9 | |
| 391 | (13) Routing : WINDOW (14) Copie s: 1 | |
| 392 | Method of Pickup : | |
| 393 | (15) Clinic : Not on F ile | |
| 394 | (16) Division : OneVA Ph armacy (98 4) | |
| 395 | (17) Pharmacist : | |
| 396 | (18) Remarks : | |
| 397 | (19) Counseling : NO | |
| 398 | (20) R efill Data | |
| 399 | F inished By : GIRLA,SA MATHA | |
| 400 | Entry B y: GIRLA,S AMATHA En try Date: 11/13/17 1 3:17:02 | |
| 401 | Enter ?? f or more ac tions | |
| 402 | DC Disco ntinue PR Partial RL Rel ease | |
| 403 | ED Edit RF (Refill) RN Ren ew | |
| 404 | Select Act ion: Quit/ / | |
| 405 | ||
| 406 | ||
| 407 | ||
| 408 | 16 | |
| 409 | Actions | |
| 410 | ||
| 411 | ||
| 412 | ||
| 413 | Select Act ion: Next Screen//1- 19 press < return> | |
| 414 | ||
| 415 | ||
| 416 | ||
| 417 | Expected R esults | |
| 418 | ||
| 419 | ||
| 420 | ||
| 421 | System sho uld be dis played fol lowing mes sage | |
| 422 | “The selec tion inclu des field( s) that ar e not edit able for c ontrolled substances . These fi eld(s) wil l be skipp ed.” | |
| 423 | The first editable f ield, fiel d2 should be display ed on the screen for user edit s | |
| 424 | When user press the return 1,3 ,11,12,17 fields sho uld not be displayed on the sc reen for e dits, rest of the ed itable fie lds should be displa yed one by one in o rder user can edit t he fields | |
| 425 | ||
| 426 | ||
| 427 | ||
| 428 | Scenario 2 :Block edi ts on rest ricted fie lds for Pe nding cont rolled sub stance pr escription s | |
| 429 | ||
| 430 | ||
| 431 | 17 | |
| 432 | Actions | |
| 433 | ||
| 434 | ||
| 435 | ||
| 436 | Execute st eps 7-14 m entioned i n scenario 1 | |
| 437 | ||
| 438 | ||
| 439 | ||
| 440 | Expected R esults | |
| 441 | ||
| 442 | ||
| 443 | ||
| 444 | Medication Profile Nov 21, 20 17@10:37:0 7 Page: 1 of 2 | |
| 445 | TEST,DAYTS HR | |
| 446 | PID: 090 -90-9090 Ht(cm): _ ______ (__ ____) | |
| 447 | DOB: JAN 1,1975 (4 2) Wt(kg): _ ______ (__ ____) | |
| 448 | SEX: FEM ALE | |
| 449 | CrCL: <No t Found> B SA (m2): _ ______ | |
| 450 | ISSUE LA ST REF DAY | |
| 451 | # RX # DRU G QTY ST DATE FI LL REM SUP | |
| 452 | ||
| 453 | ---------- ---------- ---------- -------ACT IVE------- ---------- ---------- ---------- | |
| 454 | 1 2719137 AMI NOCAPROIC ACID 500MG TAB 30 A 11-08 11- 08 11 30 | |
| 455 | 2 2719135 AMO XAPINE 100 MG TAB 30 A> 11-08 11- 08 11 30 | |
| 456 | 3 2719138 DIG OXIN (LANO XIN) 0.125 MG TAB 30 A 11-08 11- 08 11 30 | |
| 457 | 4 2719140 LOR AZEPAM 1MG TAB 30 S> 11-13 12- 03 4 30 | |
| 458 | 5 2719136 t WAR FARIN (COU MADIN) NA 10MG WHITE TAB A 11-08 11- 08 0 30 | |
| 459 | Qty: 28 | |
| 460 | ---------- ---------- ---------- ------PEND ING------- ---------- ---------- ---------- | |
| 461 | 6 ACYCLOV IR 800MG T AB QTY: 60 I SDT: 07-26 > REF: 0 | |
| 462 | ---------- ---------- ------CHYS HR TEST LA B (983) AC TIVE------ ---------- ---------- | |
| 463 | + Enter ?? f or more ac tions | |
| 464 | PU Patien t Record U pdate NO New Or der | |
| 465 | PI Patien t Informat ion SO Select Order | |
| 466 | Select Act ion: Next Screen// | |
| 467 | ||
| 468 | ||
| 469 | 18 | |
| 470 | Actions | |
| 471 | ||
| 472 | ||
| 473 | ||
| 474 | Select ava ilable Pen ding presc ription. H ere for te sting ACYC LOVIR 800M G TAB Sele ct Action: Next Scre en//6 | |
| 475 | ||
| 476 | ||
| 477 | ||
| 478 | Expected R esults | |
| 479 | ||
| 480 | ||
| 481 | ||
| 482 | Pending OP Orders (R OUTINE) Nov 21, 20 17@10:40:4 5 Page: 1 of 2 | |
| 483 | TEST,DAYTS HR | |
| 484 | PID: 090 -90-9090 Ht(cm): _ ______ (__ ____) | |
| 485 | DOB: JAN 1,1975 (4 2) Wt(kg): _ ______ (__ ____) | |
| 486 | ||
| 487 | *(1) Order able Item: ACYCLOVIR TAB | |
| 488 | (2) CMOP Drug: ACYCLOVIR 800MG TAB | |
| 489 | (3) *Dosage: 800 (MG) | |
| 490 | Verb: TAKE | |
| 491 | Dispe nse Units: 1 | |
| 492 | Noun: TABLET | |
| 493 | *Route: BY MOUTH | |
| 494 | *Schedule: 30 | |
| 495 | *Duration: 30 (DAYS) | |
| 496 | (4) Pat Instruct: Autopopul ate PatIns t on the P SO Eh X DR UG VALIDAT ION | |
| 497 | Provider Comments: | |
| 498 | Ins tructions: TAKE 1 TA BLET PO 30 30 | |
| 499 | SIG: TAKE ONE TABLET BY MOUTH 30 F OR 30 DAYS | |
| 500 | (5) Patie nt Status: SC | |
| 501 | (6) I ssue Date: JUL 26,20 17 (7) Fill D ate: NOV 2 1,2017 | |
| 502 | (8) Da ys Supply: 30 ( 9) QTY ( TAB): 60 | |
| 503 | Pro vider orde red 0 refi lls | |
| 504 | (10) # o f Refills: 0 (1 1) Routi ng: MAIL | |
| 505 | (12) Clinic: ANGIO | |
| 506 | (13) Provider: BARHAN,SH EELA MADHA R | |
| 507 | (14) Copies: 1 | |
| 508 | (15) Remarks: | |
| 509 | Entry B y: BARHAN, SHEELA MAD HAR En try Date: 08/18/17 | |
| 510 | Enter ?? f or more ac tions | |
| 511 | BY Bypass DC Discontinu e FL Flag /Unflag | |
| 512 | ED Edit FN Finish | |
| 513 | Select Ite m(s): Quit // | |
| 514 | ||
| 515 | ||
| 516 | ||
| 517 | 19 | |
| 518 | Actions | |
| 519 | ||
| 520 | ||
| 521 | ||
| 522 | Select Ite m(s): Quit //1-15 and press Ret urn | |
| 523 | ||
| 524 | ||
| 525 | ||
| 526 | Expected R esults | |
| 527 | ||
| 528 | ||
| 529 | ||
| 530 | System sho uld be dis played fol lowing mes sage | |
| 531 | “The selec tion inclu des field( s) that ar e not edit able for c ontrolled substances . These fi eld(s) wil l be skipp ed.” | |
| 532 | The first editable f ield, fiel d2 should be display ed on the screen for user edit s | |
| 533 | When user press the return 1,3 ,10,13 fie lds should not be di splayed on the scree n for edit s, rest of the edita ble fields should be displayed one by on e in orde r and use r can edit the field s | |
| 534 | ||
| 535 | ||
| 536 | Acronyms & Abbreviat ions | |
| 537 | Acronym | |
| 538 | Definition | |
| 539 | CAS | |
| 540 | Clinical A ncillary S ervices | |
| 541 | CHYSHR | |
| 542 | Test Envir onment fo r Host sit e | |
| 543 | CPRS | |
| 544 | Computeriz ed Patient Record Sy stem | |
| 545 | DAYTSHR | |
| 546 | Test Envir onment fo r the disp ensing sit e (remote) | |
| 547 | VHA | |
| 548 | Veteran’s Health Adm inistratio n | |
| 549 | VistA | |
| 550 | Veterans H ealth Info rmation Sy stems and Technology Architect ure |
Araxis Merge (but not the data content of this report) is Copyright © 1993-2016 Araxis Ltd (www.araxis.com). All rights reserved.